• Français

Ragweed allergies

A Phase III, Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-3641, a Ragweed (Ambrosia artemisiifolia) Sublingual Immunotherapy Tablet, in Children With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma.

Principal investigator

Anne Des Roches, M.D.

Selection criteria

To be eligible for this research study, your child must:

  • Be between 5 and 17 years of age
  • Have had a history of ragweed allergies s for at least 1 year (at least 1 season for ages 4 to 6 years) or at least 2 years (at least 2 seasons for ages 7 to 17 years).

There are other requirements that your child must meet to participate in the study, which we
will review during the screening process.

Contribution of the patient and/or his parents

After a screening phase of up to 12 months, you will receive assigned treatment for up to 28
weeks and followed up with a phone call for an additional 14 days. The study doctor or staff will
discuss with you when and on which days to report to the clinic.

Contact information

Isabelle Boisvert
Clinical research assistant

Research project website

About this page
Updated on 3/24/2021
Created on 11/6/2017
Alert or send a suggestion

Every dollar counts!

Thank you for your generosity.

It's people like you that allow us to accelerate research and heal more children better every year and, as such, offer among the best healthcare in the world.

It's also possible to give by mail or by calling toll-free

1-888-235-DONS (3667)

Contact Us

514 345-4931


© 2006-2014 CHU Sainte-Justine.
All rights reserved.
Terms of Use, Confidentiality, Security


Les informations contenues dans le site « CHU Sainte-Justine » ne doivent pas être utilisées comme un substitut aux conseils d’un médecin dûment qualifié et autorisé ou d’un autre professionnel de la santé. Les informations fournies ici le sont à des fins exclusivement éducatives et informatives.

Consultez votre médecin si vous croyez être malade ou composez le 911 pour toute urgence médicale.

CHU Sainte-Justine